Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD...

Por Beier, Jutta, van Noord, Jan, Deans, Amanda, Brooks, Jean, Maden, Claire, Baggen, Suus, Mehta, Rashmi, Cahn, Anthony
Publicado em 2012

In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder In...

Por Horhota, Stephen T., van Noord, Jan A., Verkleij, Cynthia B., Bour, Loek J., Sharma, Ashish, Trunk, Michael, Cornelissen, Piet J. G.
Publicado no AAPS J (2015)

Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial

Por D'Urzo, Anthony, Ferguson, Gary T, van Noord, Jan A, Hirata, Kazuto, Martin, Carmen, Horton, Rachael, Lu, Yimeng, Banerji, Donald, Overend, Tim
Publicado em 2011

Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease

Por van den Berge, Maarten, Hop, Wim CJ, van der Molen, Thys, van Noord, Jan A, Creemers, Jacques PHM, Schreurs, Ad JM, Wouters, Emiel FM, Postma, Dirkje S
Publicado em 2012